Key Details
The company is sending notices to its shareholders and creditors regarding the Scheme of Amalgamation (by Absorption) of Inzpera Healthsciences Limited (Transferor Company) with Cipla Limited (Transferee Company). Notices are being sent through electronic mode where email addresses are available and through physical mode to remaining shareholders and creditors.
Shareholder and Creditor Process
The NCLT has dispensed with the requirement for meetings of equity shareholders and unsecured creditors of Cipla Limited (Transferee Company). However, the notice provides an opportunity for shareholders and creditors to submit representations to the Hon'ble NCLT within 30 days from the date of receipt of the notice. A copy of any representation must also be sent to the company's Registered Office.
There are no secured creditors in the Transferee Company (Cipla Limited), therefore no meeting of secured creditors is required.
Document Access
The notice under section 230(5) of the Companies Act, 2013, copy of the NCLT Order, and the complete Scheme of Amalgamation can be accessed on the company's website at www.cipla.com through the provided links.
Timeline and Implications
If no representations are received by the Hon'ble NCLT within the 30-day period, it will be presumed that shareholders and creditors have no objection to the proposed scheme.